The latest new contracts, like SutroVax, Inc.’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Vaxcyte Announces Pricing of $1.3 Billion Public Offering
Sep 05, 2024•almost 2 years ago
Contract Type
contract
CaliforniaBiotechnology
Description
Vaxcyte, Inc. announced the pricing of an underwritten public offering of common stock and pre-funded warrants. The aggregate gross proceeds from this offering are expected to be approximately $1.3 billion.
CaliforniaBiotechnology